A genetically modified tumor-infiltrating lymphocytes product (GT202) exhibits enhanced persistence and anti-tumor efficacy against solid tumor in vivo

被引：0
|
作者：
Sun, Jingwei [1 ]
Jin, Jiahui [1 ]
Tan, Yongchao [1 ]
Chen, Lingyun [1 ]
Wang, Quanwei [1 ]
Liu, Yarong [1 ]
机构：
[1] Grit Biotechnol, Shanghai, Peoples R China
来源：
CANCER RESEARCH | 2022年 / 82卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5581
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Fatostatin promotes anti-tumor immunity by reducing SREBP2 mediated cholesterol metabolism in tumor-infiltrating T lymphocytes
    Zhu, Lei
    Shi, Yilin
    Feng, Zhelong
    Yuan, Dingyi
    Guo, Shiduo
    Wang, Yuxia
    Shen, Haowen
    Li, Yan
    Yan, Fang
    Wang, Yajing
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2024, 971
  • [22] Enhanced anti-tumor immunity against breast cancer induced by whole tumor cell vaccines genetically modified expressing α-Gal epitopes
    Xue, Dabing
    Liang, Ying
    Duan, Siliang
    He, Jian
    Su, Jing
    Zhu, Jianmeng
    Hu, Nan
    Liu, Jianming
    Zhao, Yongxiang
    Lu, Xiaoling
    ONCOLOGY REPORTS, 2016, 36 (05) : 2843 - 2851
  • [23] Novel strategies to improve efficacy of treatment with tumor-infiltrating lymphocytes (TILs) for patients with solid cancers
    Tas, Liselotte
    Jedema, Inge
    Haanen, John B. A. G.
    CURRENT OPINION IN ONCOLOGY, 2023, 35 (02) : 107 - 113
  • [24] Preclinical development of genetically modified tumor-infiltrating lymphocytes using biopsy samples from liver cancer patients
    Liu, M.
    Zhang, X.
    Han, D.
    Thiery, J. P.
    ANNALS OF ONCOLOGY, 2024, 35 : S695 - S695
  • [25] Enhanced in vivo anti-tumor efficacy of whole tumor lysate in combination with whole tumor cell-specific polyclonal antibody
    Rahimmanesh, Ilnaz
    Esmaili, Yasaman
    Ghafouri, Elham
    Hejazi, Seyed Hossein
    Khanahmad, Hossein
    RESEARCH IN PHARMACEUTICAL SCIENCES, 2023, 18 (02) : 138 - 148
  • [26] Fas receptor counterattack against tumor-infiltrating lymphocytes in vivo as a mechanism of immune escape in gastric carcinoma
    Koyama, S
    Koike, N
    Adachi, S
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2001, 127 (01) : 20 - 26
  • [27] Fas receptor counterattack against tumor-infiltrating lymphocytes in vivo as a mechanism of immune escape in gastric carcinoma
    Shohei Koyama
    Naoto Koike
    Shinya Adachi
    Journal of Cancer Research and Clinical Oncology, 2001, 127 : 20 - 26
  • [28] In vivo anti-tumor efficacy of polyethylene glycol-modified tumor necrosis factor-alpha against tumor necrosis factor-resistant tumors
    Tsutsumi, Y
    Tsunoda, S
    Kaneda, Y
    Kamada, H
    Kihira, T
    Nakagawa, S
    Yamamoto, Y
    Horisawa, Y
    Mayumi, T
    JAPANESE JOURNAL OF CANCER RESEARCH, 1996, 87 (10): : 1078 - 1085
  • [29] Novel gamma linoleic acid encased in situ lipogel for augmented anti-tumor efficacy against solid tumor: In vitro and in vivo evaluation
    Saad, Suma
    Hasan, Nazeer
    Siddiqui, Lubna
    Beg, Sarwar
    Ali, Asgar
    Gupta, Anshul
    Jain, Gaurav K.
    Ahmad, Farhan J.
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2023, 87
  • [30] 14-3-3ζ delivered by hepatocellular carcinoma-derived exosomes impaired anti-tumor function of tumor-infiltrating T lymphocytes
    Wang, Xiaochen
    Shen, Haiyuan
    Zhangyuan, Guangyan
    Huang, Ruyi
    Zhang, Wenjie
    He, Qifeng
    Jin, Kangpeng
    Zhuo, Han
    Zhang, Zechuan
    Wang, Jincheng
    Sun, Beicheng
    Lu, Xiaojie
    CELL DEATH & DISEASE, 2018, 9
12345